COPD, THIRD Highest Cause of Death In USA

The Centers for Disease Control and Prevention state that COPD is the THIRD leading cause of death in America.  The third.  With heart disease and cancer taking the lead.  Approximately 15 million U.S. adults are estimated to have COPD.  When combining COPD with other health issues, this can be a serious problem in the lives of your patients and loved ones.

COPD is diagnosed in four stages, each of which are characterized by a measure of lung function and measured by the breathing test spirometry.  This important test shows how much air your patients’ lungs can hold and how fast they can release the air from the lungs.

spirometry, lung function test, copd. asthma, smoking cessation tool, fev1, fvc
Primary Care Physician Spirometer Microloop hand-held spirometer with data storage and color touch screen. Features include 41 test parameters including FEV1, FVC with % predicted, diagnostic interpretation, lung age, choice of predicted normals, child incentives, post bronchodilator comparison testing for COPD and

Stage one is mild COPD.  A spirometry test will show some restriction.  A mild may be in play.

Stage two is moderate COPD.  Air flow begins to worsen at this stage.  Your patient may begin to notice a shortness of breath in activities like climbing stairs.  A cough may begin increasing and mucus production begins.  They often will have prolonged symptoms of the flu or cough.  Typically this is the stage patients start to seek treatment.

Stage three is severe COPD.  Your patient will become short of breath after very little activity and will quickly become fatigued.  Their cough will become more frequent and airflow is severely limited, with times requiring hospitalization.

Stage four is very severe COPD.  At this point, quality of life for your patient is greatly impaired and symptoms have become life-threatening.  Lung function can be dropped to 30% or less and your patient usually requires oxygen therapy on a daily basis.  Complications can arise such as weight loss, fluid build-up in the legs and feet, chronic respiratory failure and heart disease (the number ONE killer of Americans).

Catching COPD early can make all of the difference in your patients’ lives so they can live a longer, happier, and healthy life.

Take the step in caring for your patients and bring spirometry into your practice today.  Your patients will be correctly diagnosed so you can treat them more accurately and conveniently in your practice.

For more information about our Gold Standard Pulmonary Function Test—Spirometry, visit us at


Randy Clare

Randy Clare

Randy Clare brings to The Sleep and Respiratory Scholar more than 25 years of extensive knowledge and experience in the sleep and pulmonary function field. He has held numerous management positions throughout his career and has demonstrated a unique view of the alternate care diagnostic and therapy model. He is considered by many an expert in the use of oral appliances like Silent Nite, EMA and TAP to treat snoring and sleep apnea in the dental office. Mr. Clare's extensive sleep industry experience assists Sleepandrespiratoryscholar in providing current, relevant, data-proven information on sleep diagnostics and sleep therapies that are effective for the treatment of sleep disorders. Mr Clare is director of business development for Glidewell a dental solutions company his focus is on dental treatment for sleep disordered breathing.

More Posts - Website

Follow Me:
TwitterFacebookLinkedInGoogle Plus

Leave a Reply